Comparable stake leader
Third Rock Ventures V, L.P.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001984086.
Comparable stake leader
Third Rock Ventures V, L.P.
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
50/50
Latest evidence
31 Mar 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Third Rock Ventures V, L.P. |
3/4/5
13D/G
10%+ Owner
|
14%
from 13D/G
|
$54,803,075
9,368,047 shares
|
— | 28 Oct 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
13D/G
Company
|
10%
from 13D/G
|
$105,625,595
4,395,572 shares
|
— | 31 Mar 2026 |
| BIOTECHNOLOGY VALUE FUND L P |
13D/G
BVF PARTNERS L P/IL
|
3.8%
|
$42,813,056
1,720,782 shares
|
-$66,562,509 | 31 Dec 2025 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
3/4/5
Company · Director, 10%+ Owner
|
15%
|
$168,110,468
6,995,858 shares
|
— | 31 Mar 2026 |
| TRV GP V, LLC |
13F
Company
|
14%
|
$149,360,652
6,215,591 shares
|
— | 31 Mar 2026 |
| TRV GP VI, LLC |
13F
Company
|
9.3%
|
$101,206,166
4,211,659 shares
|
— | 31 Mar 2026 |
| Samsara BioCapital, LLC |
13F
Company
|
7%
|
$75,673,546
3,149,128 shares
|
— | 31 Mar 2026 |
| GOLDMAN SACHS GROUP INC |
13F
Company
|
6.4%
|
$69,841,441
2,906,427 shares
|
— | 31 Mar 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to selling over the last 12 months. Net value: -$3,725,560.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 48,494 | $0 | $1,566,638 | -$1,566,638 |
| 3-6 | 0 | 74,453 | $0 | $2,095,699 | -$2,095,699 |
| 6-9 | 0 | 3,501 | $0 | $63,223 | -$63,223 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Showing 1-20 of 23 reporting-owner rows connected to Septerna, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Third Rock Ventures VI, L.P. | 10%+ Owner | $62,553,072 | Mixed | 24 Feb 2025 | ||
| Third Rock Ventures V, L.P. | 10%+ Owner | $54,803,075 | Mixed | 28 Oct 2024 | ||
| RA CAPITAL MANAGEMENT, L.P. | Director, 10%+ Owner | $8,610,867 | Mixed | 26 Jun 2026 | ||
| Elizabeth Bhatt | President and COO | $4,505,445 | -$213,204 | -4.5% | Filing P/S | 15 Apr 2026 |
| Daniel D. Long | SVP, Drug Discovery | $3,356,497 | -$710,333 | -17% | Filing P/S | 01 Jul 2026 |
| Jeffrey Finer | Chief Executive Officer, Director | $2,282,263 | Mixed | 06 Feb 2026 | ||
| Uwe Klein | SVP, Biological Sciences | $1,477,880 | Mixed | 06 Feb 2026 | ||
| Alan Ezekowitz | Director | $813,451 | Filing P/S | 26 Jun 2026 | ||
| Ran Xiao | Interim CFO | $339,704 | Mixed | 24 Oct 2024 | ||
| Gil M. Labrucherie | Chief Financial Officer | $234,000 | Filing P/S | 06 Feb 2026 | ||
| Samira Shaikhly | Chief People Officer | $27,897 | -$2,802,023 | -99% | Filing P/S | 29 Jun 2026 |
| Shalini Sharp | Director | Mixed | 26 Jun 2026 | |||
| Jake Simson | Director | Mixed | 26 Jun 2026 | |||
| Jeffrey K. Tong | Director | Mixed | 26 Jun 2026 | |||
| Abraham Bassan | Director | Mixed | 26 Jun 2026 | |||
| Bernard Coulie | Director | Mixed | 26 Jun 2026 | |||
| Keith Michael Gottesdiener | Director | Mixed | 26 Jun 2026 | |||
| Mark A. Wilson | Chief Legal Officer | Mixed | 06 Feb 2026 | |||
| RA Capital Healthcare Fund LP | Director, 10%+ Owner | Mixed | 26 Jun 2026 | |||
| RA Capital Nexus Fund III, L.P. | Director | Mixed | 26 Jun 2026 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Daniel D. Long | SEPN | Common Stock | Sale | -3.34% | $114,528 | $34.36 | -3,333 | 96,412 | 01 Jul 2026 | Direct |
| Daniel D. Long | SEPN | Common Stock | Options Exercise | 3.46% | 3,333 | 99,745 | 01 Jul 2026 | Direct | ||
| Daniel D. Long | SEPN | Stock Option (Right to Buy) | Options Exercise | -32.1% | -3,333 | 7,043 | 01 Jul 2026 | Direct | ||
| Samira Shaikhly | SEPN | Common Stock | Sale | -73.3% | $76,622 | $35.18 | -2,178 | 793 | 29 Jun 2026 | Direct |
| Samira Shaikhly | SEPN | Common Stock | Options Exercise | 274.6% | 2,178 | 2,971 | 29 Jun 2026 | Direct | ||
| Samira Shaikhly | SEPN | Stock Option (Right to Buy) | Options Exercise | -9.45% | -2,178 | 20,865 | 29 Jun 2026 | Direct | ||
| RA CAPITAL MANAGEMENT, L.P. | SEPN | Stock Option (Right to Buy) | Award | 15,000 | 15,000 | 26 Jun 2026 | See Footnotes | |||
| RA CAPITAL MANAGEMENT, L.P. | SEPN | Stock Option (Right to Buy) | Award | 15,000 | 15,000 | 26 Jun 2026 | See Footnotes | |||
| Ra Capital Management, L.P. | SEPN | Stock Option (Right to Buy) | Award | 15,000 | 15,000 | 26 Jun 2026 | See Footnotes | |||
| Ra Capital Management, L.P. | SEPN | Stock Option (Right to Buy) | Award | 15,000 | 15,000 | 26 Jun 2026 | See Footnotes | |||
| Ra Capital Management, L.P. | SEPN | Stock Option (Right to Buy) | Award | 15,000 | 15,000 | 26 Jun 2026 | See Footnotes | |||
| Abraham Bassan | SEPN | Stock Option (Right to Buy) | Award | 15,000 | 15,000 | 26 Jun 2026 | Direct | |||
| Shalini Sharp | SEPN | Stock Option (Right to Buy) | Award | 15,000 | 15,000 | 26 Jun 2026 | Direct | |||
| Bernard Coulie | SEPN | Stock Option (Right to Buy) | Award | 15,000 | 15,000 | 26 Jun 2026 | Direct | |||
| Jeffrey K. Tong | SEPN | Stock Option (Right to Buy) | Award | 15,000 | 15,000 | 26 Jun 2026 | Direct | |||
| Keith Michael Gottesdiener | SEPN | Stock Option (Right to Buy) | Award | 11,260 | 11,260 | 26 Jun 2026 | Direct | |||
| Alan Ezekowitz | SEPN | Stock Option (Right to Buy) | Award | 15,000 | 15,000 | 26 Jun 2026 | Direct | |||
| Jake Simson | SEPN | Stock Option (Right to Buy) | Award | 15,000 | 15,000 | 26 Jun 2026 | Direct | |||
| Daniel D. Long | SEPN | Common Stock | Sale | -13.5% | $532,582 | $35.51 | -15,000 | 96,412 | 22 Jun 2026 | Direct |
| Daniel D. Long | SEPN | Common Stock | Options Exercise | 15.6% | 15,000 | 111,412 | 22 Jun 2026 | Direct | ||
| Daniel D. Long | SEPN | Stock Option (Right to Buy) | Options Exercise | -59.1% | -15,000 | 10,376 | 22 Jun 2026 | Direct | ||
| Samira Shaikhly | SEPN | Common Stock | Sale | -88.7% | $219,224 | $35.08 | -6,250 | 793 | 12 Jun 2026 | Direct |
| Samira Shaikhly | SEPN | Common Stock | Options Exercise | 788.2% | 6,250 | 7,043 | 12 Jun 2026 | Direct | ||
| Samira Shaikhly | SEPN | Stock Option (Right to Buy) | Options Exercise | -20.8% | -6,250 | 23,750 | 12 Jun 2026 | Direct | ||
| Samira Shaikhly | SEPN | Common Stock | Sale | -88.2% | $171,682 | $28.93 | -5,935 | 793 | 01 Jun 2026 | Direct |
| Samira Shaikhly | SEPN | Common Stock | Options Exercise | 748.4% | 5,935 | 6,728 | 01 Jun 2026 | Direct | ||
| Samira Shaikhly | SEPN | Stock Option (Right to Buy) | Options Exercise | -70.2% | -5,935 | 2,517 | 01 Jun 2026 | Direct | ||
| Samira Shaikhly | SEPN | Common Stock | Sale | -93.7% | $354,656 | $30.06 | -11,798 | 793 | 26 May 2026 | Direct |
| Samira Shaikhly | SEPN | Common Stock | Options Exercise | 1487.8% | 11,798 | 12,591 | 26 May 2026 | Direct | ||
| Samira Shaikhly | SEPN | Stock Option (Right to Buy) | Options Exercise | -33.9% | -11,798 | 23,043 | 26 May 2026 | Direct | ||
| Elizabeth Bhatt | SEPN | Common Stock | Sale | -2.24% | $97,343 | $24.34 | -4,000 | 174,209 | 15 Apr 2026 | Direct |
| Elizabeth Bhatt | SEPN | Common Stock | Options Exercise | 2.3% | 4,000 | 178,209 | 15 Apr 2026 | Direct | ||
| Elizabeth Bhatt | SEPN | Stock Option (Right to Buy) | Options Exercise | -4.5% | -4,000 | 84,911 | 15 Apr 2026 | Direct | ||
| Samira Shaikhly | SEPN | Common Stock | Sale | -98.9% | $1,979,838 | $28.10 | -70,453 | 793 | 02 Mar 2026 | Direct |
| Samira Shaikhly | SEPN | Common Stock | Options Exercise | 8884.4% | 70,453 | 71,246 | 02 Mar 2026 | Direct | ||
| Samira Shaikhly | SEPN | Stock Option (Right to Buy) | Options Exercise | -95.3% | -70,453 | 3,460 | 02 Mar 2026 | Direct | ||
| Elizabeth Bhatt | SEPN | Common Stock | Sale | -2.24% | $115,860 | $28.97 | -4,000 | 174,209 | 18 Feb 2026 | Direct |
| Elizabeth Bhatt | SEPN | Common Stock | Options Exercise | 2.3% | 4,000 | 178,209 | 18 Feb 2026 | Direct | ||
| Elizabeth Bhatt | SEPN | Stock Option (Right to Buy) | Options Exercise | -4.31% | -4,000 | 88,911 | 18 Feb 2026 | Direct | ||
| Daniel D. Long | SEPN | Stock Option (Right to Buy) | Award | 80,000 | 80,000 | 06 Feb 2026 | Direct | |||
| Uwe Klein | SEPN | Stock Option (Right to Buy) | Award | 80,000 | 80,000 | 06 Feb 2026 | Direct | |||
| Samira Shaikhly | SEPN | Stock Option (Right to Buy) | Award | 80,000 | 80,000 | 06 Feb 2026 | Direct | |||
| Gil M. Labrucherie | SEPN | Stock Option (Right to Buy) | Award | 125,000 | 125,000 | 06 Feb 2026 | Direct | |||
| Jae B. Kim | SEPN | Stock Option (Right to Buy) | Award | 125,000 | 125,000 | 06 Feb 2026 | Direct | |||
| Elizabeth Bhatt | SEPN | Stock Option (Right to Buy) | Award | 155,000 | 155,000 | 06 Feb 2026 | Direct | |||
| Jeffrey Finer | SEPN | Stock Option (Right to Buy) | Award | 400,000 | 400,000 | 06 Feb 2026 | Direct | |||
| Mark A. Wilson | SEPN | Stock Option (Right to Buy) | Award | 165,000 | 165,000 | 06 Feb 2026 | Direct | |||
| Daniel D. Long | SEPN | Common Stock | Sale | -3.63% | $63,223 | $18.06 | -3,501 | 92,911 | 10 Nov 2025 | Direct |
| Keith Michael Gottesdiener | SEPN | Stock Option (Right to Buy) | Award | 33,246 | 33,246 | 25 Sep 2025 | Direct | |||
| Uwe Klein | SEPN | Common Stock | Options Exercise | 23,008 | 23,008 | 18 Aug 2025 | Direct |